EQT Fund Management S.a r.l.

Est. AUM

$1.02B

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	WAYSTAR HLDG CORP	COM	$599.8M	24879437	58.77%	SOLE
2	OCULIS HOLDING AG	ORDINARY SHARES	$156.9M	5900294	15.37%	SOLE
3	EVOMMUNE INC	COM SHS	$113.3M	4929633	11.10%	SOLE
4	PHARVARIS N V	COM	$96.7M	3424609	9.48%	SOLE
5	AGOMAB THERAPEUTICS NV	SPONSORED ADS	$53.9M	5141992	5.28%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.